Business Consultant

Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust

Business Consultant, Pharma Consultant, Pharma news

Incyte meets endpoint in the second pivotal atopic dermatitis clinical trial A second phase 3 trial of Incyte’s ruxolitinib cream in...

Read More

Cardiovascular Disease: A major cause of health loss and a global burden

Business Consultant, Pharma Consultant, Snippets

Cardiovascular diseases (CVDs) are one of the leading causes of death and health loss in people in the US. As per a study by the National...

Read More

Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D

Articles, Business Consultant, Pharma Consultant

Nearly 11 million Americans are living with one or other type of Age-Related Macular degeneration (AMD), estimates BrightFocus foundation....

Read More

J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug

Business Consultant, News, Pharma Consultant

J&J collaborates with BARDA to accelerate coronavirus vaccine program Johnson & Johnson has collaborated with the U.S. Biomedical...

Read More

Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma

Articles, Business Consultant, Pharma Consultant

FDA has accepted Biological License Application submitted by Kite for its CAR-T cell therapy- KTE-X19, for relapsed or refractory mantle...

Read More

Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline

Articles, Business Consultant, Pharma Consultant

Slowly or rapidly growing bacteria- Nontuberculous mycobacteria (NTM), might appear innocuous, however, NTM infections have a notably...

Read More
Close